read more

first_imgTime Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how… read more News | September 30, 2013 Average Phase I Trial Costs Approach $9,000 Per Patient Per Month A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow… read more Related Content News | April 06, 2009 Lantheus Acquires Rights to MRA Contrast Agent for Peripheral Vascular Imaging April 7, 2009 – Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (… read more News | October 05, 2009 Lexiscan Agent for MPI Meets the Standard October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine… read more News | June 16, 2008 Free Cell Phone Minutes, Texting Used to Help Monitor TB Treatment June 17, 2008 – One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic read more News | June 09, 2008 Federal Government Issues Guidance for Stockpiling Pandemic Flu Antivirals Feature | April 02, 2012 Seeing is Believing With Clogged Arteries It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most… read more center_img Feature | February 21, 2013 Time Does Deep Dive Into Healthcare, Identifies Flaws in Reform News | March 25, 2014 Study Shows Heart Scans Not Always Useful in Prescribing Statins As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it… read more News | July 10, 2009 Blood Vessel Bends; Branches Put Brakes on Statins July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way… read more News | November 18, 2011 High-Res MRI Can Be Used to Test Cholesterol Drug Efficacy November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic… read more June 10, 2008 – The U.S. Department of Health and Human Services (HHS) June 3 released two draft guidance documents for businesses on the stockpiling and use of antiviral medications as part of pandemic flu planning.The two guidance documents, “Proposed Considerations for Antiviral Drug Stockpiling by Employers in Preparation for an Influenza Pandemic” and “Proposed Guidance on Antiviral Drug Use During an Influenza Pandemic,” were developed by an interagency working group including members from HHS, the Homeland Security Department, the Department of Labor, public health organizations and state/local health departments The purpose of the guidance is help employers (both public and private sector) with informed planning and implementation decisions on antiviral drug stockpiling for pandemic influenza. If drugs are stockpiled, the guidance is designed to assure the drugs are maintained and used optimally.The federal government encourages companies to consider stockpiling antivirals for use during an influenza pandemic as part of a comprehensive approach. Private stockpiles, in coordination with public health stockpiles, would extend protection more broadly than could be achieved through the public sector alone. The documents also state these extra stockpiles will improve the ability to achieve the national pandemic response goals of mitigating disease, suffering, and death, and minimizing impacts on the economy and functioning of society.The World Health Organization (WHO) May 6, health officials warned that not only is pandemic flu still a threat, but the risk of a pandemic is probably growing as the H5N1 virus continues to spread and become entrenched in bird populations in more countries.“The threat (of a pandemic) has by no means receded, and we would be very unwise to let down our guard, or slacken our preparedness measures,” said Margaret Chan, director general of the WHO. “As with climate change, all countries will be affected, though in a far more rapid and sweeping way.” Institute of Medicine (IOM) report issued in April said the U.S. government will need to expand its stockpile of antivirals if the goal is to treat all patients and also provide preventive treatment. The federal government has established a goal of acquiring 81 million treatment courses of antivirals in federal and state stockpiles, but the report states that in a pandemic, it may take more than twice that amount to treat sick patients and offer preventive doses to people at risk for exposure on the job.“The media buzz has died down, but the bird flu virus has not,” said Michael Leavitt, secretary of HHS, in a March 17 statement. “The federal government cannot mount an effective response to the threats we face as a nation without partners at every level of government and throughout society.” For more information: www.pandemicflu.gov/plan/panflureport5.html FacebookTwitterLinkedInPrint分享 News | June 08, 2008 Curlin Awarded Pain Management, Local Anesthetic Contract by Premier June 9, 2008 – Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-loca read morelast_img

Leave a Reply

Your email address will not be published. Required fields are marked *